(GIB) CGI - Overview
Exchange: NYSE •
Country: Canada •
Currency: USD •
Type: Common Stock •
ISIN: CA12532H1047
Stock: Consulting, Integration, Managed Services, Applications, Infrastructure
Total Rating 43
Risk 78
Buy Signal -0.95
| Risk 5d forecast | |
|---|---|
| Volatility | 24.1% |
| Relative Tail Risk | -2.48% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.39 |
| Alpha | -39.82 |
| Character TTM | |
|---|---|
| Beta | 0.465 |
| Beta Downside | -0.014 |
| Drawdowns 3y | |
|---|---|
| Max DD | 41.98% |
| CAGR/Max DD | -0.16 |
EPS (Earnings per Share)
Revenue
Description: GIB CGI March 04, 2026
CGI Inc. (GIB) is a Canadian company providing information technology and business process services globally. The company offers a comprehensive suite of services, from IT consulting and systems integration to managed IT and application services. This broad service offering is typical for large IT services firms competing for enterprise contracts.
GIBs services include specialized areas like AI and automation integration, cloud management, and DevSecOps. The company also provides infrastructure services, including cybersecurity and cloud cost management (FinOps). The IT services sector is characterized by rapid technological advancements, requiring continuous adaptation of service offerings.
CGI serves a diverse client base across numerous industries, including banking, government, healthcare, and manufacturing. This wide client portfolio helps mitigate risks associated with reliance on a single sector. To understand how GIBs financial performance compares to its peers, further research on ValueRay is recommended.
Piotroski VR‑10 (Strict, 0-10) 8.5
| Net Income: 1.66b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.12 > 0.02 and ΔFCF/TA 0.54 > 1.0 |
| NWC/Revenue: -1.81% < 20% (prev 8.95%; Δ -10.76% < -1%) |
| CFO/TA 0.13 > 3% & CFO 2.46b > Net Income 1.66b |
| Net Debt (3.97b) to EBITDA (2.89b): 1.38 < 3 |
| Current Ratio: 0.94 > 1.5 & < 3 |
| Outstanding Shares: last quarter (217.7m) vs 12m ago -4.63% < -2% |
| Gross Margin: 20.56% > 18% (prev 0.16%; Δ 2039 % > 0.5%) |
| Asset Turnover: 88.00% > 50% (prev 82.90%; Δ 5.11% > 0%) |
| Interest Coverage Ratio: 18.67 > 6 (EBITDA TTM 2.89b / Interest Expense TTM 126.7m) |
Altman Z'' 3.15
| A: -0.02 (Total Current Assets 4.57b - Total Current Liabilities 4.86b) / Total Assets 18.90b |
| B: 0.39 (Retained Earnings 7.29b / Total Assets 18.90b) |
| C: 0.13 (EBIT TTM 2.37b / Avg Total Assets 18.41b) |
| D: 1.07 (Book Value of Equity 9.63b / Total Liabilities 8.96b) |
| Altman-Z'' Score: 3.15 = A |
Beneish M -2.53
| DSRI: 1.72 (Receivables 2.75b/1.47b, Revenue 16.20b/14.86b) |
| GMI: 0.80 (GM 20.56% / 16.45%) |
| AQI: 1.10 (AQ_t 0.71 / AQ_t-1 0.64) |
| SGI: 1.09 (Revenue 16.20b / 14.86b) |
| TATA: -0.04 (NI 1.66b - CFO 2.46b) / TA 18.90b) |
| Beneish M-Score: -2.53 (Cap -4..+1) = A |
What is the price of GIB shares?
As of March 05, 2026, the stock is trading at USD 73.01 with a total of 298,456 shares traded.
Over the past week, the price has changed by +2.93%, over one month by -11.58%, over three months by -20.06% and over the past year by -28.53%.
Over the past week, the price has changed by +2.93%, over one month by -11.58%, over three months by -20.06% and over the past year by -28.53%.
Is GIB a buy, sell or hold?
CGI has received a consensus analysts rating of 3.94.
Therefore, it is recommended to buy GIB.
- StrongBuy: 4
- Buy: 9
- Hold: 1
- Sell: 2
- StrongSell: 0
What are the forecasts/targets for the GIB price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 90.3 | 23.7% |
| Analysts Target Price | 90.3 | 23.7% |
GIB Fundamental Data Overview March 05, 2026
Market Cap CAD = 21.51b (15.74b USD * 1.3664 USD.CAD)
P/E Trailing = 13.2717
P/E Forward = 11.0497
P/S = 0.9714
P/B = 2.1333
P/EG = 1.1986
Revenue TTM = 16.20b CAD
EBIT TTM = 2.37b CAD
EBITDA TTM = 2.89b CAD
Long Term Debt = 2.77b CAD (from longTermDebt, last quarter)
Short Term Debt = 998.0m CAD (from shortTermDebt, last quarter)
Debt = 4.81b CAD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.97b CAD (from netDebt column, last quarter)
Enterprise Value = 25.48b CAD (21.51b + Debt 4.81b - CCE 836.4m)
Interest Coverage Ratio = 18.67 (Ebit TTM 2.37b / Interest Expense TTM 126.7m)
EV/FCF = 11.45x (Enterprise Value 25.48b / FCF TTM 2.23b)
FCF Yield = 8.73% (FCF TTM 2.23b / Enterprise Value 25.48b)
FCF Margin = 13.73% (FCF TTM 2.23b / Revenue TTM 16.20b)
Net Margin = 10.25% (Net Income TTM 1.66b / Revenue TTM 16.20b)
Gross Margin = 20.56% ((Revenue TTM 16.20b - Cost of Revenue TTM 12.87b) / Revenue TTM)
Gross Margin QoQ = 16.02% (prev 33.53%)
Tobins Q-Ratio = 1.35 (Enterprise Value 25.48b / Total Assets 18.90b)
Interest Expense / Debt = 0.67% (Interest Expense 32.0m / Debt 4.81b)
Taxrate = 26.31% (157.7m / 599.3m)
NOPAT = 1.74b (EBIT 2.37b * (1 - 26.31%))
Current Ratio = 0.94 (Total Current Assets 4.57b / Total Current Liabilities 4.86b)
Debt / Equity = 0.48 (Debt 4.81b / totalStockholderEquity, last quarter 9.94b)
Debt / EBITDA = 1.38 (Net Debt 3.97b / EBITDA 2.89b)
Debt / FCF = 1.79 (Net Debt 3.97b / FCF TTM 2.23b)
Total Stockholder Equity = 10.15b (last 4 quarters mean from totalStockholderEquity)
RoA = 9.02% (Net Income 1.66b / Total Assets 18.90b)
RoE = 16.37% (Net Income TTM 1.66b / Total Stockholder Equity 10.15b)
RoCE = 18.31% (EBIT 2.37b / Capital Employed (Equity 10.15b + L.T.Debt 2.77b))
RoIC = 12.65% (NOPAT 1.74b / Invested Capital 13.78b)
WACC = 6.33% (E(21.51b)/V(26.32b) * Re(7.63%) + D(4.81b)/V(26.32b) * Rd(0.67%) * (1-Tc(0.26)))
Discount Rate = 7.63% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -3.53%
[DCF] Terminal Value 85.27% ; FCFF base≈2.14b ; Y1≈2.28b ; Y5≈2.75b
[DCF] Fair Price = 352.8 (EV 71.23b - Net Debt 3.97b = Equity 67.26b / Shares 190.6m; r=6.33% [WACC]; 5y FCF grow 7.39% → 2.90% )
EPS Correlation: 89.98 | EPS CAGR: 8.90% | SUE: 4.0 | # QB: 2
Revenue Correlation: 93.22 | Revenue CAGR: 6.09% | SUE: 0.02 | # QB: 0
EPS next Quarter (2026-06-30): EPS=2.29 | Chg7d=+0.000 | Chg30d=-0.014 | Revisions Net=-4 | Analysts=10
EPS current Year (2026-09-30): EPS=8.95 | Chg7d=+0.000 | Chg30d=-0.014 | Revisions Net=+0 | Growth EPS=+7.9% | Growth Revenue=+5.1%
EPS next Year (2027-09-30): EPS=9.75 | Chg7d=+0.000 | Chg30d=+0.025 | Revisions Net=+0 | Growth EPS=+8.8% | Growth Revenue=+3.2%
[Analyst] Revisions Ratio: -0.40 (3 Up / 7 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 0.4% (Discount Rate 7.9% - Earnings Yield 7.5%)
[Growth] Growth Spread = +3.3% (Analyst 3.7% - Implied 0.4%)
P/E Trailing = 13.2717
P/E Forward = 11.0497
P/S = 0.9714
P/B = 2.1333
P/EG = 1.1986
Revenue TTM = 16.20b CAD
EBIT TTM = 2.37b CAD
EBITDA TTM = 2.89b CAD
Long Term Debt = 2.77b CAD (from longTermDebt, last quarter)
Short Term Debt = 998.0m CAD (from shortTermDebt, last quarter)
Debt = 4.81b CAD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.97b CAD (from netDebt column, last quarter)
Enterprise Value = 25.48b CAD (21.51b + Debt 4.81b - CCE 836.4m)
Interest Coverage Ratio = 18.67 (Ebit TTM 2.37b / Interest Expense TTM 126.7m)
EV/FCF = 11.45x (Enterprise Value 25.48b / FCF TTM 2.23b)
FCF Yield = 8.73% (FCF TTM 2.23b / Enterprise Value 25.48b)
FCF Margin = 13.73% (FCF TTM 2.23b / Revenue TTM 16.20b)
Net Margin = 10.25% (Net Income TTM 1.66b / Revenue TTM 16.20b)
Gross Margin = 20.56% ((Revenue TTM 16.20b - Cost of Revenue TTM 12.87b) / Revenue TTM)
Gross Margin QoQ = 16.02% (prev 33.53%)
Tobins Q-Ratio = 1.35 (Enterprise Value 25.48b / Total Assets 18.90b)
Interest Expense / Debt = 0.67% (Interest Expense 32.0m / Debt 4.81b)
Taxrate = 26.31% (157.7m / 599.3m)
NOPAT = 1.74b (EBIT 2.37b * (1 - 26.31%))
Current Ratio = 0.94 (Total Current Assets 4.57b / Total Current Liabilities 4.86b)
Debt / Equity = 0.48 (Debt 4.81b / totalStockholderEquity, last quarter 9.94b)
Debt / EBITDA = 1.38 (Net Debt 3.97b / EBITDA 2.89b)
Debt / FCF = 1.79 (Net Debt 3.97b / FCF TTM 2.23b)
Total Stockholder Equity = 10.15b (last 4 quarters mean from totalStockholderEquity)
RoA = 9.02% (Net Income 1.66b / Total Assets 18.90b)
RoE = 16.37% (Net Income TTM 1.66b / Total Stockholder Equity 10.15b)
RoCE = 18.31% (EBIT 2.37b / Capital Employed (Equity 10.15b + L.T.Debt 2.77b))
RoIC = 12.65% (NOPAT 1.74b / Invested Capital 13.78b)
WACC = 6.33% (E(21.51b)/V(26.32b) * Re(7.63%) + D(4.81b)/V(26.32b) * Rd(0.67%) * (1-Tc(0.26)))
Discount Rate = 7.63% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -3.53%
[DCF] Terminal Value 85.27% ; FCFF base≈2.14b ; Y1≈2.28b ; Y5≈2.75b
[DCF] Fair Price = 352.8 (EV 71.23b - Net Debt 3.97b = Equity 67.26b / Shares 190.6m; r=6.33% [WACC]; 5y FCF grow 7.39% → 2.90% )
EPS Correlation: 89.98 | EPS CAGR: 8.90% | SUE: 4.0 | # QB: 2
Revenue Correlation: 93.22 | Revenue CAGR: 6.09% | SUE: 0.02 | # QB: 0
EPS next Quarter (2026-06-30): EPS=2.29 | Chg7d=+0.000 | Chg30d=-0.014 | Revisions Net=-4 | Analysts=10
EPS current Year (2026-09-30): EPS=8.95 | Chg7d=+0.000 | Chg30d=-0.014 | Revisions Net=+0 | Growth EPS=+7.9% | Growth Revenue=+5.1%
EPS next Year (2027-09-30): EPS=9.75 | Chg7d=+0.000 | Chg30d=+0.025 | Revisions Net=+0 | Growth EPS=+8.8% | Growth Revenue=+3.2%
[Analyst] Revisions Ratio: -0.40 (3 Up / 7 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 0.4% (Discount Rate 7.9% - Earnings Yield 7.5%)
[Growth] Growth Spread = +3.3% (Analyst 3.7% - Implied 0.4%)